Navigation Links
Stryker Announces Exclusive Collaboration With RegenLab
Date:7/8/2011

SAN DIEGO, July 8, 2011 /PRNewswire/ -- Stryker Joint Preservation, a business unit of Stryker's Orthopaedics group, today announced at the 2011 American Orthopaedic Society for Sports Medicine meeting that it has entered into an exclusive collaboration with RegenLab SA to distribute Stryker's RegenKit-THT, a one-step system designed for the safe and rapid preparation of autologous platelet-rich plasma (A-PRP) from a small sample of blood at the patient's point of care.

A-PRP contains an increased concentration of platelets, while maintaining physiological levels of leukocytes (white blood cells).  When activated, platelets have been found to release growth factors which may participate in the healing process, and a multitude of proteins and bioactive factors critical to the healing process and the recruitment of cells.  Leukocytes are responsible primarily for defending the body against infection, but are also key players during the initial inflammation phase of tissue healing.

In comparison to competitive offerings, the A-PRP prepared using Stryker's RegenKit-THT provides the highest platelet recovery and viability(1), while its simplified single tube preparation, with a minimal eight minute centrifuge spin time and reduced number of steps, helps maximize efficiency in the office and O.R.

"The RegenKit-THT system is the result of 10 years of scientific research in tissue regeneration and is designed to provide an autologous and physiological solution to promote a biological environment for regenerative cells enrichment.  RegenLab is pleased to collaborate with Stryker, a leader in medical technologies and innovation, which will allow for the widespread distribution of our A-PRP technology," said Antoine Turzi, Founder and CEO of RegenLab SA.

"The addition of the RegenKit for PRP therapy to Stryker's Joint Preservation Biologics portfolio allows us to provide surgeons with this emerging therapy for orthopaedic applications.  We're pleased to collaborate with RegenLab on the distribution of this system," said Matt Moreau, Vice President & General Manager, Stryker Joint Preservation.

To see a demonstration of this product, please visit Stryker at booth #503 at AOSSM.

About Stryker OrthopaedicsStryker Orthopaedics is a division of the Stryker Corporation, one of the world's leading medical technology companies. Stryker Orthopaedics offers an extensive orthopaedic product portfolio including hip, knee and upper extremity reconstructive devices, bone cement, trauma implants, bone substitutes, joint preservation products and spine systems. For more information about Stryker Orthopaedics, visit: http://www.stryker.com/en-us/products/Orthopaedics/index.htm

About StrykerStryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. For more information about Stryker, please visit www.stryker.com.

(1) Study Report – Regen™ THT Tube Performance Testing, USFDA 510(k) BK090048, May 2010, Data on file at RegenLab, Switzerland.

NL11-FB-CO-1532Contact:Jeanine GuilfoyleStryker Orthopaedics201-831-6277jeanine.guilfoyle@stryker.com
'/>"/>

SOURCE Stryker Orthopaedics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Stryker Launches VersiTomic G-Lok™
2. Stryker Orthopaedics Launches Its First iPad™ Apps for Surgeons, Available Through Apples App Store(SM)
3. Stryker Features Tissue-Preservation Hip Arthroscopy Platform, Sponsors Surgeon Education Events at the AAOS Annual Meeting
4. Fred Funk Becomes Spokesperson for Stryker Orthopaedics
5. Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System
6. Stryker Declares a $0.18 Per Share Quarterly Dividend
7. Stryker Completes Sale of OP-1 for use in Orthopaedic Bone Applications to Olympus
8. Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010
9. Stryker Corporation Named One of FORTUNE Magazines 100 Best Companies to Work For
10. TriMed, Inc. Announces Licensing Agreement with Stryker
11. Stryker Increases Expected 2010 Results and Provides 2011 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... S.C. , July 10, 2017  BDI ... purchasing and patient support services organization serving specialty ... today the launch of four significant, value-added member ... market insights, better manage reimbursement and improve access ... and factor therapies. ...
(Date:7/5/2017)... 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... received approval from the Israel Securities Authority to dual-list its ... common stock will commence trading on the TASE on July ... market capitalization of the Company, it is expected that Oramed ...
(Date:6/30/2017)... -- AVACEN Medical (AVACEN) announced the publication of new research in the ... its AVACEN Treatment Method to significantly reduce the widespread ... ... ... approximately 200 to 400 million people worldwide according to The National ...
Breaking Medicine Technology:
(Date:7/24/2017)... SANTA CLARA, CA (PRWEB) , ... July 24, 2017 , ... ... government and financial organizations, today announced it has partnered with WALLIX to ... NIST Special Publication 800-171 . , There are a number of ways to address ...
(Date:7/24/2017)... ... July 24, 2017 , ... Anyone who uses scales know they ... would a pharmacist using that same scale to dispense medication. The first example is ... These illustrations show why it is important to have the right balance for the ...
(Date:7/24/2017)... ... 24, 2017 , ... A Southern California-based author has released a new book ... she has overcome them. “Forbidden Memories: A Memoir,” by author Michelle V. Madsen, highlights ... risen above. , In “Memories,” readers get a firsthand look at what Michelle has ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... how to change manufacturers future. , The agency is hammering out a game ... one of the farthest-ranging laws ever to affect FDA-regulated firms. The new law:, ...
(Date:7/24/2017)... ... 24, 2017 , ... “A Short Walk to the Mailbox”: a remarkable memoir ... of published author, Ed Clark. Ed Clark is a church music director and ... a minister of music and worship leader for over fifty years. He has ...
Breaking Medicine News(10 mins):